If you have asthma, you may have an asthma action plan with a "stoplight system" to help you recognize and respond to changes and understand when symptoms are getting worse and need more attention.
If you're in the green zone, you're doing well, yellow means your asthma has worsened and action is needed, and red means you require urgent care. New guidelines are now available to help your allergist steer you out of the yellow zone, back into green and away from the red zone.
"Management of acute loss of asthma control in the yellow zone: a practice parameter," is published in the August issue of Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI).
The practice parameter was developed for providers to help their asthma patients understand what to do in the yellow zone to prevent moving into the red zone. The recommendations are intended to help patients recognize and treat acute loss of asthma control.
They apply to the home setting only; not providers' offices, emergency departments or hospital settings. The ideal intervention, according to the new parameter should "provide quick relief of symptoms, prevent progression to the red zone, be safe enough to initiate at home, be convenient and practical for self-administration, be portable so that it is always available and be cost-effective."
Ask your allergist about the new asthma parameter. For more information about asthma, and to locate an allergist in your area, visit AllergyAndAsthmaRelief.org.
The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyAndAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.
Hollis Heavenrich-Jones | Eurek Alert!
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy